Meghmani Organics Limited (NSE:MOL)

Market Cap	24.00B
Revenue (ttm)	22.79B
Net Income (ttm)	188.41M
Shares Out	254.31M
EPS (ttm)	0.74
PE Ratio	127.35
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,381,281
Average Volume	1,644,609
Open	98.99
Previous Close	99.16
Day's Range	94.00 - 101.85
52-Week Range	56.11 - 115.95
Beta	0.15
RSI	44.70
Earnings Date	Aug 8, 2025

About Theseus Pharmaceuticals

Meghmani Organics Limited manufactures and sells pigments and agrochemicals in India and internationally. The company offers green and blue pigments, which are used in printing inks, paints and coatings, and plastics. It also offers agrochemical products comprising insecticides, which include acetamiprid, alphacypermethrin, bifenthrin, betacyfluthrin, cyfluthrin, cypermethrin, deltamethrin, dinotefuran, ethiprole, fipronil, flonicamid, flubendiamide, lambdacyhalothrin, permethrin, profenofos, pymetrozine, pyriproxyfen, and spiromesifen. in addi...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 1986
• Employees: 1,234
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MOL

Financial Performance

In 2024, Meghmani Organics's revenue was 20.80 billion, an increase of 32.78% compared to the previous year's 15.66 billion. Losses were -106.01 million, -90.00% less than in 2023.